drugset / Trial / NCT02806895

Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA

NCT02806895

Phase 2 Completed 34 enrolled Jazz Pharmaceuticals
RandomizedCrossoverDouble-blindTreatment

Summary

This trial is a randomized, double-blind, placebo-controlled, crossover study to evaluate the effect of JZP-110 on driving performance in subjects with excessive sleepiness due to obstructive sleep apnea.

Timeline

Start
2016-07-05
Primary completion
2019-05-28
Completion
2019-05-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Solriamfetol Small molecule 300 mg